@article{ref1,
title="Asp Viper (Vipera aspis) Envenomation: Experience of the Marseille Poison Centre from 1996 to 2008",
journal="Toxins (Basel)",
year="2009",
author="de Haro, Luc and Glaizal, Mathieu and Tichadou, Lucia and Blanc-Brisset, Ingrid and Hayek-Lanthois, Maryvonne",
volume="1",
number="2",
pages="100-112",
abstract="A retrospective case review study of viper envenomations collected by the Marseille's Poison Centre between 1996 and 2008 was performed. RESULTS: 174 cases were studied (52 grade 1 = G1, 90 G2 and 32 G3). G1 patients received symptomatic treatments (average hospital stay 0.96 day). One hundred and six (106) of the G2/G3 patients were treated with the antivenom Viperfav* (2.1+/-0.9 days in hospital), while 15 of them received symptomatic treatments only (plus one immediate death) (8.1+/-4 days in hospital, 2 of them died). The hospital stay was significantly reduced in the antivenom treated group (p < 0.001), and none of the 106 antivenom treated patients had immediate (anaphylaxis) or delayed (serum sickness) allergic reactions. CONCLUSION: Viperfav* antivenom was safe and effective for treating asp viper venom-induced toxicity.<p /> <p>Language: en</p>",
language="en",
issn="2072-6651",
doi="10.3390/toxins1020100",
url="http://dx.doi.org/10.3390/toxins1020100"
}